Yuan‐Lin Guo

823 total citations
54 papers, 561 citations indexed

About

Yuan‐Lin Guo is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yuan‐Lin Guo has authored 54 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Surgery, 24 papers in Cardiology and Cardiovascular Medicine and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yuan‐Lin Guo's work include Lipoproteins and Cardiovascular Health (30 papers), Cancer, Lipids, and Metabolism (14 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers). Yuan‐Lin Guo is often cited by papers focused on Lipoproteins and Cardiovascular Health (30 papers), Cancer, Lipids, and Metabolism (14 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers). Yuan‐Lin Guo collaborates with scholars based in China, United States and United Kingdom. Yuan‐Lin Guo's co-authors include Na‐Qiong Wu, Cheng‐Gang Zhu, Jian‐Jun Li, Rui‐Xia Xu, Jian‐Jun Li, Qian Dong, Sha Li, Jing‐Lu Jin, Geng Liu and Qian Dong and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yuan‐Lin Guo

50 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuan‐Lin Guo China	14	286	202	120	88	62	54	561
Gaojun Cai China	14	247 0.9×	258 1.3×	202 1.7×	107 1.2×	63 1.0×	44	717
Mika Mori Japan	12	307 1.1×	168 0.8×	172 1.4×	67 0.8×	56 0.9×	46	598
Pyung Chun Oh South Korea	14	229 0.8×	268 1.3×	126 1.1×	100 1.1×	57 0.9×	62	631
Carlo Giammarresi Italy	11	298 1.0×	318 1.6×	86 0.7×	83 0.9×	53 0.9×	26	661
Sarah Nomura United States	12	217 0.8×	129 0.6×	187 1.6×	64 0.7×	47 0.8×	29	615
Insa E. Emrich Germany	14	131 0.5×	145 0.7×	71 0.6×	52 0.6×	88 1.4×	42	616
Songbai Deng China	17	272 1.0×	337 1.7×	106 0.9×	50 0.6×	157 2.5×	44	702
Young Sup Byun South Korea	13	337 1.2×	361 1.8×	84 0.7×	53 0.6×	55 0.9×	64	688
Michael K. Palmer United Kingdom	15	423 1.5×	125 0.6×	211 1.8×	62 0.7×	69 1.1×	20	786

Countries citing papers authored by Yuan‐Lin Guo

Since Specialization

Citations

This map shows the geographic impact of Yuan‐Lin Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan‐Lin Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan‐Lin Guo more than expected).

Fields of papers citing papers by Yuan‐Lin Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan‐Lin Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan‐Lin Guo. The network helps show where Yuan‐Lin Guo may publish in the future.

Co-authorship network of co-authors of Yuan‐Lin Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan‐Lin Guo. A scholar is included among the top collaborators of Yuan‐Lin Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan‐Lin Guo. Yuan‐Lin Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ding, Wenbo, et al.. (2025). Impact of LDL-C and apolipoprotein B level discordance and associated lipoprotein particle alterations on cardiovascular outcomes in a large primary prevention population. European Journal of Preventive Cardiology.

Zhu, Cheng‐Gang, et al.. (2024). Prognostic Value of Plasma Endothelin-1 in Predicting Worse Outcomes in Patients with Prediabetes and Diabetes and Stable Coronary Artery Diseases. Diabetes & Metabolism Journal. 48(5). 993–1002. 5 indexed citations

Liu, Huihui, Sha Li, Yan Zhang, et al.. (2024). Joint Association of Lipoprotein(a) and a Family History of Coronary Artery Disease with the Cardiovascular Outcomes in Patients with Chronic Coronary Syndrome. Journal of Atherosclerosis and Thrombosis. 31(9). 1319–1332. 1 indexed citations

Guo, Yuan‐Lin, et al.. (2024). The U-shaped association between remnant cholesterol and risk of all-cause and cardiovascular deaths in diabetic adults: Findings from NHANES 1999–2018. Nutrition Metabolism and Cardiovascular Diseases. 34(10). 2282–2288. 4 indexed citations

Zhu, Cheng‐Gang, Yuan‐Lin Guo, Na‐Qiong Wu, et al.. (2024). Synergetic impact of lipoprotein(a) and fibrinogen on stroke in coronary artery disease patients. European Journal of Clinical Investigation. 54(6). e14179–e14179. 6 indexed citations

Jin, Jing‐Lu, Huiwen Zhang, Qian Dong, et al.. (2023). The value of HDL subfractions in predicting cardiovascular outcomes in untreated, diabetic patients with stable coronary artery disease: An age- and gender-matched case-control study. Frontiers in Endocrinology. 13. 1041555–1041555. 3 indexed citations

Wang, Zeping, Yajie Wu, Ying Gao, et al.. (2023). Different clinical phenotypes of a pair of siblings with familial hypercholesterolemia: a case report and literature review. BMC Cardiovascular Disorders. 23(1). 227–227.

Wu, Yi‐Long, Minjie Qi, Lijuan Song, et al.. (2023). Associations of remnant cholesterol with cardiovascular and cancer mortality in a nationwide cohort. Science Bulletin. 69(4). 526–534. 28 indexed citations

Liu, Mingming, Jia Peng, Yuan‐Lin Guo, et al.. (2022). SORBS2 as a molecular target for atherosclerosis in patients with familial hypercholesterolemia. Journal of Translational Medicine. 20(1). 233–233. 8 indexed citations

10.

Zhang, Huiwen, Jing‐Lu Jin, Ye‐Xuan Cao, et al.. (2021). Association of diabetes mellitus with clinical outcomes in patients with different coronary artery stenosis. Cardiovascular Diabetology. 20(1). 214–214. 14 indexed citations

11.

Cui, Chuan-Jue, Jing‐Lu Jin, Linna Guo, et al.. (2020). Beneficial impact of epigallocatechingallate on LDL-C through PCSK9/LDLR pathway by blocking HNF1α and activating FoxO3a. Journal of Translational Medicine. 18(1). 195–195. 34 indexed citations

12.

Wu, Na‐Qiong, Yuan‐Lin Guo, Cheng‐Gang Zhu, et al.. (2019). Lipoprotein(a) and coronary artery disease in Chinese postmenopausal female patients: a large cross-sectional cohort study. Postgraduate Medical Journal. 95(1128). 534–540. 13 indexed citations

13.

Sun, Di, Xi Zhao, Sha Li, et al.. (2018). Lipoprotein(a) level associates with coronary artery disease rather than carotid lesions in patients with familial hypercholesterolemia. Journal of Clinical Laboratory Analysis. 32(7). e22442–e22442. 15 indexed citations

14.

Li, Sha, Xiaolin Li, Cheng‐Gang Zhu, et al.. (2016). C-reactive protein as a predictor for poor collateral circulation in patients with chronic stable coronary heart disease. Annals of Medicine. 48(1-2). 83–88. 12 indexed citations

15.

Xu, Ruijun, Yuan‐Lin Guo, Na‐Qiong Wu, et al.. (2016). Analysis of the association between plasma PCSK9 and Lp(a) in Han Chinese. Journal of Endocrinological Investigation. 39(8). 875–883. 11 indexed citations

16.

Li, Sha, Ping Ye, Hong Chen, et al.. (2015). Lipid profiles in nontreated Chinese patients with stable coronary artery disease: a cross-sectional study. Clinical Lipidology. 10(5). 369–378. 1 indexed citations

17.

Xu, Rui‐Xia, Na‐Qiong Wu, Sha Li, et al.. (2015). Effects of Hedan Tablet (荷丹片) on lipid profile, proprotein convertase subtilisin/kexin type 9 and high-density lipoprotein subfractions in patients with hyperlipidemia: A primary study. Chinese Journal of Integrative Medicine. 22(9). 660–665. 4 indexed citations

18.

Li, Xiaolin, Yuan‐Lin Guo, Cheng‐Gang Zhu, et al.. (2014). Impact of admission triglyceride for early outcome in diabetic patients with stable coronary artery disease. Lipids in Health and Disease. 13(1). 73–73. 9 indexed citations

19.

Li, Xiaolin, Jian‐Jun Li, Yuan‐Lin Guo, et al.. (2014). Relationship of Glycated Hemoglobin Levels with Myocardial Injury following Elective Percutaneous Coronary Intervention in Patients with Type 2 Diabetes Mellitus. PLoS ONE. 9(7). e101719–e101719. 7 indexed citations

20.

Chen, Juan, Manhua Chen, Yuan‐Lin Guo, et al.. (2014). Plasma Big Endothelin-1 Level and the Severity of New-onset Stable Coronary Artery Disease. Journal of Atherosclerosis and Thrombosis. 22(2). 126–135. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact